68Ga-PSMA PET/CT检出肝细胞癌隐匿性骨转移
本文报告一例82岁肝细胞癌患者,经导管动脉化疗栓塞术后6个月肿瘤标志物升高但CT表现稳定,68Ga-PSMA PET/CT显示高PSMA表达的富血供肝病灶(原发肿瘤)、额外多灶性肝病灶及意外多发骨转移。肝细胞癌的68Ga-PSMA表达可影响患者管理并可能指导放射性配体治疗。
要点
- 肝癌患者肿瘤标志物升高而CT稳定时,68Ga-PSMA PET/CT可检出隐匿性骨转移。
- 肝细胞癌病灶可高表达PSMA,表现为富血供肝病灶及多灶肝病灶。
- 68Ga-PSMA表达可能影响肝癌患者管理并指导放射性配体治疗。
核心结论
- 68Ga-PSMA PET/CT在肝细胞癌患者中检出意外多发骨转移,肝细胞癌可高表达PSMA。
研究设计与样本
- 个案报告:1例82岁肝细胞癌患者,经导管动脉化疗栓塞术后6个月行68Ga-PSMA PET/CT。
主要发现
- 患者肿瘤标志物升高但CT表现稳定。
- 68Ga-PSMA PET/CT显示高PSMA表达的富血供肝病灶(原发肿瘤)及额外多灶性肝病灶。
- 68Ga-PSMA PET/CT意外检出多发骨转移。
临床怎么用
- 肝癌患者肿瘤标志物升高而常规影像稳定时,可考虑68Ga-PSMA PET/CT评估隐匿转移。
- 肝细胞癌PSMA表达可能指导放射性配体治疗决策。
局限性
- 本文为单例个案报告,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
68Ga-PSMA is an excellent radiotracer for both staging and detection of recurrence in prostate cancer, but it can also be useful in other solid tumors due to tumor-associated angiogenic factors and endothelial cell sprouting. We report a case of an 82-year-old man with hepatocellular carcinoma who presented with rising tumor marker but stable CT findings 6 months after transarterial chemoembolization. 68Ga-PSMA PET/CT showed high PSMA-expressing hyperneovascular hepatic lesions (primary tumor), additional multifocal hepatic lesions, and with unexpected multiple bone metastases. 68Ga-PSMA expression in hepatocellular carcinoma can influence patient management and potentially guide radionuclide legend therapy.
引用
- Usmani S, Rasheed R, Al Kandari F, et al. Occult Bone Metastases From Hepatocellular Carcinoma Detected on 68Ga-PMSA PET/CT. Clin Nucl Med. 2021. PMID: 33512948. doi:10.1097/RLU.0000000000003515
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。